# Anlotinib inhibits angiogenesis via suppressing the activation of VEGFR2, PDGFRβ and FGFR1

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/anlotinib-inhibits-angiogenesis-via-suppressing-the-activation-of-vegfr2-pdgfr/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Binyan Lin,Xiuming Song,Dawei Yang,Bai Dongsheng,Yuyuan Yao,Na Lu |
| Citations | 398 |
| DOI | 10.1016/j.gene.2018.02.026 |
| Fields | Biochemistry, Genetics and Molecular Biology |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2793605704 |
| PMID | 29454091 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Na Lu](https://scholariq.org/researchers/na-lu/)

## Paper primary topic

- [Angiogenesis and VEGF in Cancer](https://scholariq.org/topics/angiogenesis-and-vegf-in-cancer/)

## Paper topics

- [Angiogenesis and VEGF in Cancer](https://scholariq.org/topics/angiogenesis-and-vegf-in-cancer/)
- [Proteoglycans and glycosaminoglycans research](https://scholariq.org/topics/proteoglycans-and-glycosaminoglycans-research/)
- [Fibroblast Growth Factor Research](https://scholariq.org/topics/fibroblast-growth-factor-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
